Health In Tech, Inc. (HIT) News
Track canonical SquawkNews coverage tagged to HIT, Health In Tech, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Health In Tech reports Q2 2026 revenue, reaffirms guidance
Health In Tech (NASDAQ: HIT) reported Q2 2026 GAAP revenue of $8.1 million versus $9.3 million a year ago, posted negative adjusted EBITDA of $1.3 million, and reaffirmed full-year 2026 revenue guidance of $45 million to
EARNINGS | Aug 13, 2026, 10:08 PM UTC
L
Health In Tech reaffirms FY2026 sales guidance of $45M-$50M
Health In Tech (NASDAQ: HIT) affirms its FY2026 sales outlook at $45.000M-$50.000M, unchanged from prior guidance and versus a $46.813M estimate.
EARNINGS | Aug 13, 2026, 08:31 PM UTC
L
Health In Tech (HIT) reports Second Quarter 2026 financial results
Health In Tech (HIT) reports its second quarter 2026 financial results, according to the provided headline and body text.
EARNINGS | Aug 13, 2026, 08:30 PM UTC
L
HIT - Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026
HIT - Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026
EARNINGS | Aug 03, 2026, 08:06 PM UTC